University of Maryland Greenebaum Comprehensive Cancer Center and AstraZeneca Partner to Enhance Community Based Lung Cancer Screening and Detection for Marylanders at High Risk
April 16, 2024With only a small percentage of Marylanders at high risk for lung cancer getting the recommended annual screening, the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) today launched a new statewide effort to increase annual screenings.